Discontinued — last reported Q3 '25
Operating
Non-Cash Lease Expense
ResMed Non-Cash Lease Expense decreased by 19.2% to $10.05M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.1%, from $8.24M to $10.05M. Over 4 years (FY 2021 to FY 2025), Non-Cash Lease Expense shows relatively stable performance with a 1.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2018
Last reportedQ3 2025
How to read this metric
An increase suggests an expansion of the company's physical footprint or equipment leasing arrangements.
Detailed definition
This reflects the non-cash amortization of right-of-use assets associated with operating leases under accounting standar...
Peer comparison
Standard for all companies reporting under modern lease accounting standards.
Metric ID:
operating_lease_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.88M | $8.52M | $8.82M | $9.30M | $7.60M | $7.76M | $7.77M | $8.43M | $8.44M | $8.51M | $8.59M | $11.17M | $11.08M | $8.98M | $9.46M | $8.24M | $10.66M | $9.97M | $12.45M | $10.05M |
| QoQ Change | — | -4.0% | +3.5% | +5.5% | -18.3% | +2.2% | +0.1% | +8.5% | +0.1% | +0.8% | +0.9% | +30.1% | -0.8% | -18.9% | +5.4% | -13.0% | +29.4% | -6.5% | +24.8% | -19.2% |
| YoY Change | — | — | — | — | -14.4% | -8.9% | -11.9% | -9.3% | +11.1% | +9.6% | +10.5% | +32.4% | +31.3% | +5.5% | +10.2% | -26.3% | -3.8% | +11.0% | +31.5% | +22.1% |
Range$7.60M – $12.45M
CAGR+2.7%
Avg YoY Growth+6.3%
Median YoY Growth+9.9%
Non-Cash Lease Expense at Other Companies
Frequently Asked Questions
- What is ResMed's non-cash lease expense?
- ResMed (RMD) reported non-cash lease expense of $10.05M in Q1 2026.
- How has ResMed's non-cash lease expense changed year-over-year?
- ResMed's non-cash lease expense increased by 22.1% year-over-year, from $8.24M to $10.05M.
- What is the long-term trend for ResMed's non-cash lease expense?
- Over 4 years (2021 to 2025), ResMed's non-cash lease expense has grown at a 1.3% compound annual growth rate (CAGR), from $35.50M to $37.34M.
- What does non-cash lease expense mean?
- The non-cash accounting charge for the use of leased assets.